AQR Capital's Q1'25 portfolio hits $97.07B, with top picks in AAPL, NVDA, & AMZN. Active portfolio adjustments show a ...

That challenge, of finding or building good, useable data sets, is also one of the biggest differentiators in an increasingly ...

The recent experience of Chinese biotech companies in developing their own drug candidates and inking deals with larger ...

The biopharma company—whose US headquarters is in Atlanta—will be building a new biologics manufacturing facility in a city ...

MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...